US health insurers embrace gene therapy

$2m per treatment

Adam Saville
clock
US health insurers embrace gene therapy

CVS Health joins list of healthcare companies aiming to make gene therapy accessible through employer

According to a recent white paper, the US-based firm plans to spread the high cost of gene therapy for its members following its 2018 acquisition of Aetna. CVS Health also plans to launch a new insurance product in March to absorb the financial risk of covering these therapies. It joins two other healthcare companies in the US developing ways to mitigate the cost of gene therapy for employees. In September last year, Cigna added a programme where members pay by month to access a feat...

To continue reading this article...

Join Cover

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Adviser / Broking

In Review: The first half of 2022 in protection

In Review: The first half of 2022 in protection

"Let’s hope to see some examples of real innovation from the industry in the second half of the year"

John Brazier
clock 01 August 2022 • 4 min read
MAXIS Global Benefits Network partners with Further Group on CI offering

MAXIS Global Benefits Network partners with Further Group on CI offering

Further is seventh supplier to join network

Hemma Visavadia
clock 28 July 2022 • 1 min read
How protection networks adapted in the face of global crises

How protection networks adapted in the face of global crises

From pandemics to economic turmoil

Christopher Marchant
clock 28 July 2022 • 7 min read